Company Update

Concord Drugs has announced that physical letters are being dispatched to shareholders whose email addresses are not registered, providing the web link and navigation path to access the annual report and upcoming annual general meeting details.

This outreach ensures that unregistered investors can view corporate disclosures and underscores the company's push for digital communication compliance.

Shareholders are urged to update their contact details promptly with their depository participants or the registrar to facilitate seamless future updates and maintain uninterrupted access to essential corporate governance documents.